Sunitinib: a novel tyrosine kinase inhibitor. A brief review of its therapeutic potential in the treatment of renal carcinoma and gastrointestinal stromal tumors (GIST)

Tekijä Le Tourneau, Christophe, Raymond, Eric, Faivre, Sandrine
Julkaistu 2007

Novel TGF-β inhibitors ready for prime time in onco-immunology

Tekijä de Gramont, Armand, Faivre, Sandrine, Raymond, Eric
Julkaisussa Oncoimmunology (2016)

Sunitinib in advanced pancreatic neuroendocrine tumors: latest evidence and clinical potential

Tekijä Delbaldo, Catherine, Faivre, Sandrine, Dreyer, Chantal, Raymond, Eric
Julkaistu 2012

Impact of the COVID-19 Outbreak on the Management of Patients with Cancer

Tekijä Raymond, Eric, Thieblemont, Catherine, Alran, Severine, Faivre, Sandrine
Julkaisussa Target Oncol (2020)

Adjuvant therapies in advanced hepatocellular carcinoma: moving forward from the STORM

Tekijä Bouattour, Mohamed, Soubrane, Olivier, de Gramont, Armand, Faivre, Sandrine
Julkaisussa Trials (2016)

Targeting cancer cell metabolism in pancreatic adenocarcinoma

Tekijä Cohen, Romain, Neuzillet, Cindy, Tijeras-Raballand, Annemilaï, Faivre, Sandrine, de Gramont, Armand, Raymond, Eric
Julkaisussa Oncotarget (2015)

Recent developments of c‐Met as a therapeutic target in hepatocellular carcinoma

Tekijä Bouattour, Mohamed, Raymond, Eric, Qin, Shukui, Cheng, Ann‐Lii, Stammberger, Uz, Locatelli, Giuseppe, Faivre, Sandrine
Julkaisussa Hepatology (2018)

Insights on the CXCL12-CXCR4 axis in hepatocellular carcinoma carcinogenesis

Tekijä Ghanem, Ismael, Riveiro, Maria E, Paradis, Valerie, Faivre, Sandrine, de Parga, Paula M Vázquez, Raymond, Eric
Julkaistu 2014

Perspectives of TGF-β inhibition in pancreatic and hepatocellular carcinomas

Tekijä Neuzillet, Cindy, de Gramont, Armand, Tijeras-Raballand, Annemilaï, de Mestier, Louis, Cros, Jérome, Faivre, Sandrine, Raymond, Eric
Julkaistu 2013

Pharmacokinetics and safety of DTS-108, a human oligopeptide bound to SN-38 with an esterase-sensitive cross-linker in patients with advanced malignancies: a Phase I study

Tekijä Coriat, Romain, Faivre, Sandrine J, Mir, Olivier, Dreyer, Chantal, Ropert, Stanislas, Bouattour, Mohammed, Desjardins, Robert, Goldwasser, François, Raymond, Eric
Julkaisussa Int J Nanomedicine (2016)

Predictive Factors of Sensitivity to Elisidepsin, a Novel Kahalalide F-Derived Marine Compound

Tekijä Serova, Maria, de Gramont, Armand, Bieche, Ivan, Riveiro, Maria Eugenia, Galmarini, Carlos Maria, Aracil, Miguel, Jimeno, José, Faivre, Sandrine, Raymond, Eric
Julkaistu 2013

Alternative Response Criteria (Choi, European Association for the Study of the Liver, and Modified Response Evaluation Criteria in Solid Tumors [RECIST]) Versus RECIST 1.1 in Patie...

Tekijä Ronot, Maxime, Bouattour, Mohamed, Wassermann, Johanna, Bruno, Onorina, Dreyer, Chantal, Larroque, Béatrice, Castera, Laurent, Vilgrain, Valérie, Belghiti, Jacques, Raymond, Eric, Faivre, Sandrine
Julkaistu 2014

Disease control with sunitinib in advanced intrahepatic cholangiocarcinoma resistant to gemcitabine-oxaliplatin chemotherapy

Tekijä Dreyer, Chantal, Sablin, Marie-Paule, Bouattour, Mohamed, Neuzillet, Cindy, Ronot, Maxime, Dokmak, Safi, Belghiti, Jacques, Guedj, Nathalie, Paradis, Valérie, Raymond, Eric, Faivre, Sandrine
Julkaisussa World J Hepatol (2015)

Effects of TGF-beta signalling inhibition with galunisertib (LY2157299) in hepatocellular carcinoma models and in ex vivo whole tumor tissue samples from patients

Tekijä Serova, Maria, Tijeras-Raballand, Annemilaï, Santos, Célia Dos, Albuquerque, Miguel, Paradis, Valerie, Neuzillet, Cindy, Benhadji, Karim A., Raymond, Eric, Faivre, Sandrine, de Gramont, Armand
Julkaisussa Oncotarget (2015)

Multimodal strategy for the management of sphenoid osteoradionecrosis: Preliminary results

Tekijä Daoudi, Hannah, Labeyrie, Marc A., Guillerm, Sophie, Delanian, Sylvie, Guichard, Jean‐Pierre, Jourdaine, Clément, Faivre, Sandrine, Gauthier, Helene, Ferrand, François‐Régis, Verillaud, Benjamin, Herman, Philippe
Julkaisussa Laryngoscope Investig Otolaryngol (2020)

ANTICANCER ACTIVITY OF PYRIPLATIN, A MONOFUNCTIONAL CATIONIC PLATINUM(II) COMPOUND, IN HUMAN CANCER CELLS

Tekijä Lovejoy, Katherine S., Serova, Maria, Bieche, Ivan, Emami, Shahin, D'Incalci, Maurizio, Broggini, Massimo, Erba, Eugenio, Gespach, Christian, Cvitkovic, Esteban, Faivre, Sandrine, Raymond, Eric, Lippard, Stephen J.
Julkaistu 2011

Cancer wars: natural products strike back

Tekijä Basmadjian, Christine, Zhao, Qian, Bentouhami, Embarek, Djehal, Amel, Nebigil, Canan G., Johnson, Roger A., Serova, Maria, de Gramont, Armand, Faivre, Sandrine, Raymond, Eric, Désaubry, Laurent G.
Julkaistu 2014

Comparative analysis of the phase III clinical trials of anti-PD1 monotherapy in head and neck squamous cell carcinoma patients (CheckMate 141 and KEYNOTE 040)

Tekijä Pai, Sara I., Faivre, Sandrine, Licitra, Lisa, Machiels, Jean-Pascal, Vermorken, Jan B., Bruzzi, Paolo, Gruenwald, Viktor, Giglio, Raul E., Leemans, C. René, Seiwert, Tanguy Y., Soulieres, Denis
Julkaisussa J Immunother Cancer (2019)

Determination of an optimal response cut-off able to predict progression-free survival in patients with well-differentiated advanced pancreatic neuroendocrine tumours treated with...

Tekijä Lamarca, Angela, Barriuso, Jorge, Kulke, Matthew, Borbath, Ivan, Lenz, Heinz-Josef, Raoul, Jean Luc, Meropol, Neal J, Lombard-Bohas, Catherine, Posey, James, Faivre, Sandrine, Raymond, Eric, Valle, Juan W
Julkaisussa Br J Cancer (2018)

Mechanism-related circulating proteins as biomarkers for clinical outcome in patients with unresectable hepatocellular carcinoma receiving sunitinib

Tekijä Harmon, Charles S, DePrimo, Samuel E, Raymond, Eric, Cheng, Ann-Lii, Boucher, Eveline, Douillard, Jean-Yves, Lim, Ho Y, Kim, Jun S, Lechuga, Maria José, Lanzalone, Silvana, Lin, Xun, Faivre, Sandrine
Julkaistu 2011